Sydney M Crago is a journalist who specializes in optometry and ophthalmology. She writes for Optometry Times and Ophthalmology Times, covering topics such as clinical studies, research findings, and advancements in eye health. With a focus on providing accurate and informative content, Sydney aims to keep eyecare professionals and readers updated on the latest developments in the field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Not enough data
Sydney M Crago’s articles predominantly cover medical research, with a focus on eye health and pharmaceutical industry developments. The coverage includes presentations of scientific data, expert commentary, and announcements related to these topics.
If you are looking to pitch to Sydney M Crago, consider offering expert commentary or insights into recent medical research developments in the field of ophthalmology and pharmaceuticals. Additionally, if you have access to new scientific data or can provide analysis based on such information, it may be particularly appealing for her audience.
Given the specific nature of the topics covered by Sydney M Crago, content related to deep learning in medical research or updates from prestigious associations like ASRS (American Society of Retina Specialists) could also be well-received.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: David Hutton, Grace Koennecke, Sydney M Crago, Sheryl Stevenson
John Josephson, MD, from the Eye Specialists and Surgeons of Northern Virginia, shared insights on office-based surgeries and how it allows for the addition of new technologies and new procedures at this year's AAO meeting held in Chicago, Illinois.
By: David Hutton, Sydney M Crago, Hattie Hayes, Sheryl Stevenson
Victoria L Tseng, MD, PhD, spoke with the Eye Care Network at this year's AAO meeting about the "Glaucoma Original Papers" session and discussed the papers presented in the session by Giovanni Montesano, MD; Jason D Horowitz, MD; Christopher M Edwards, BS; Eamonn Thomas Fahy, BMBCH; Kiana Tavakoli, MD; Hani El Helwe, MD; and Joseph F Panarelli, MD.
By: David Hutton, Martin David Harp, Sydney M Crago, Sheryl Stevenson
Alfredo Sadun, MD, PhD, is the chief of Ophthalmology at the Doheny Eye Institute of UCLA. At this year's AAO meeting held in Chicago, Illinois, he stopped by the Eye Care Network booth to share insights from the symposium "Professional Longevity 2.0: Assessing the Ophthalmologist," which he presented during.
By: Sydney M Crago
Scientists at Scripps Research and its nonprofit drug development arm, the Calibr-Skaggs Institute for Innovative Medicines, are working to advance regenerative medicines capable of repairing tissues damaged by age-related disease
By: Sydney M Crago
ABI-110 has the potential to offer a durable and effective solution by addressing the root causes of wet AMD at the genetic level.
By: Martin David Harp, Sheryl Stevenson, David Hutton, Sydney M Crago
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.
By: Martin David Harp, Sydney M Crago, David Hutton, Sheryl Stevenson
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.
By: Sydney M Crago, David Hutton, Sheryl Stevenson, Martin David Harp
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
By: Sydney M Crago, Sheryl Stevenson, Martin David Harp, David Hutton
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
By: Sheryl Stevenson, David Hutton, Sydney M Crago, Martin David Harp
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
(833) 317-6278 